GRM5 and peripheral nerve injury: Based on these findings, our aim was to investigate whether viral delivery of mGluR5-shRNA, specifically targeting the knockdown of mGluR5 expression in astrocytes, could reverse the changes observed in mice with neuropathic pain induced by peripheral nerve injury.